000 | 01453 a2200397 4500 | ||
---|---|---|---|
005 | 20250512010724.0 | ||
264 | 0 | _c19900201 | |
008 | 199002s 0 0 eng d | ||
022 | _a0305-7453 | ||
024 | 7 |
_a10.1093/jac/24.5.787 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSteen, H J | |
245 | 0 | 0 |
_aClinical and pharmacokinetic aspects of ciprofloxacin in the treatment of acute exacerbations of pseudomonas infection in cystic fibrosis patients. _h[electronic resource] |
260 |
_bThe Journal of antimicrobial chemotherapy _cNov 1989 |
||
300 |
_a787-95 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 |
_aCiprofloxacin _xadverse effects |
650 | 0 | 4 |
_aCystic Fibrosis _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
650 | 0 | 4 | _aRespiratory Function Tests |
650 | 0 | 4 |
_aSputum _xmetabolism |
700 | 1 | _aScott, E M | |
700 | 1 | _aStevenson, M I | |
700 | 1 | _aBlack, A E | |
700 | 1 | _aRedmond, A O | |
700 | 1 | _aCollier, P S | |
773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 24 _gno. 5 _gp. 787-95 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/24.5.787 _zAvailable from publisher's website |
999 |
_c2605896 _d2605896 |